L-isoleucine-supplemented oral rehydration solution in the treatment of acute diarrhoea in children: A randomized controlled trial

Journal of Health, Population and Nutrition

Volumn 29, Issue 3, 2011, Pages 183-190

  Alam, N H ^a   Raqib, R ^a   Ashraf, H ^a   Qadri, F ^a   Ahmed, S ^a   Zasloff, M ^b   Agerberth, B ^c   Salam, M A ^a   Gyr, N ^d   Meier, R ^e  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b GEORGETOWN UNIVERSITY   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e Kantonsspital Liestal   (Switzerland)

Author keywords

Acute; Bangladesh; Dehydration; Diarrhoea; Double blind method; Infantile; Oral rehydration solutions; Randomized controlled trials

Indexed keywords

EID: 79960447108     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: 10.3329/jhpn.v29i3.7864     Document Type: Article

References (28)

1. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 2003;81:197-204.
2. Patra FC, Sack DA, Islam A, Alam AN, Mazumder RN. Oral rehydration formula containing alanine and glucose for treatment of diarrhoea: a controlled trial. BMJ 1989:298:1353-6.
3. International Group on Improved ORS. Impact of glycine-containing oral rehydration solutions on stool output and duration of diarrhoea: a meta-analysis of seven clinical trials. Bull World Health Organ 1991;69:541-8.
4. Bhan MK, Mahalanabis D, Fontaine O, Pierce NF. Clinical trials of improved oral rehydration salt formulations: a review. Bull World Health Organ 1994;72:945-55.
5. Gore SM, Fontaine O, Pierce NF. Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. BMJ 1992;304:287-91.
6. Hahn S, kim Y, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration due to diarrhoea in children: systematic review. BMJ 2001;323:81-5.
7. World Health Organization. Reduced osmolarity oral rehydration salts (ORS) formulation. New York, NY: World Health Organization, 2001. 12 p. (WHO/FCH/CAH/01.22).
8. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-95.
9. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors of in bacteria? (review). Nat Rev Microbiol 2005;3:238-50.
10. Ganz T, Lehrer RI. Defensins Pharmacol Ther 1995; 66:191-205.
11. Stolzenberg ED, Anderson GM, Ackermann MR, Whitlock RH, Zasloff M. Epithelial antibiotic induced in states of disease. Proc Natl Acad Sci USA 1997;94:8686-90.
12. Zhao C, Wang I, Lehrer RI. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996;396:319-22.
13. Schonwetter BS, Stolzenberg ED, Zasloff MA. Epithelial antibiotics induced at sites of inflammation. Science 1995;267:1645-8.
14. Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature 1997;387:861.
15. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997;88:553-60.
16. Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS, Stratman J et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defence. Science 1999;286:113-7.
17. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J et al. Beta-defensin: linking innate and adaptive immunity through dentritic and T cell CCR6. Science 1999;286:525-38.
18. Diamond G, Russel JP, Bevins CL. Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc Natl Acad Sci USA 1996;93:5156-60.
19. Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature 1997;387:861.
20. Russell JP, Diamond G, Tarver AP, Scanlin TF, Bevins CL. Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor. Infect Immun 1996;64:1565-8.
21. Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway BA et al. Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci USA 1998;95:14961-6.
22. Mathews M, Jia HP, Guthmiller JM, Losh G, Graham S, Johnson GK et al. Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun 1999;67:2740-5.
23. Raqib R, Sarker P, Bergman P, Ara G, Lindh M, Sack DA et al. Improved outcome in shigellosis associated with butyrate induction of endogenous peptide antibiotics. Proc Natl Acad Sci USA 2006;03:9178-83.
24. Sherman H, Chapnik N, Froy O. Albumin and amino acids upregulate the expression of human beta-defensin Mol Immunol 2006;43:1617-23.
25. Fehlbaum P, Rao M, Zasloff M, Anderson GM. An essential amino acid induces epithelial beta-defensin expression. Proc Natl Acad Sci USA 2000;97:12723-28.
26. World Health Organization. The treatment of diarrhoea: a manual for physicians and other senior health workers. Geneva: World Health Organization, 2005. 44 p. (WHO/CDR/95.3).
27. Ahmed FE, James SI, Lysle DT, Dobbs LJ Jr, Johnke RM, Flake G et al. Improved methods for extracting RNA from exfoliated human colonocytes in stool and RT-PCR analysis. Dig Dis Sci 2004;49:1889-98.
28. Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 2001;7:180-5.